Role of daratumumab in relapsed or refractory multiple myeloma patient: A meta-analysis and literature to review

INTRODUCTION: With an increase in number of cases of relapsed or refractory multiple myeloma (RRMM), scientist have discovered various combination of medications among which one is daratumumab, Daratumumab is a mono-clonal antibody which attacks CD-38 markers present in abundance on the surface of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Tauseef, Abubakar, Zafar, Maryam, Silberstein, Peter, Nahas, Joseph, Frederickson, Thomas, Abodunrin, Faith, Abbas, Anum, Arshad, Wafa, Lateef, Noman, Rangoonwala, Hussain, Albagoush, Sara, Mirza, Mohsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480675/
https://www.ncbi.nlm.nih.gov/pubmed/36119264
http://dx.doi.org/10.4103/jfmpc.jfmpc_1987_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480675/
https://www.ncbi.nlm.nih.gov/pubmed/36119264
http://dx.doi.org/10.4103/jfmpc.jfmpc_1987_21

Ejemplares similares